Rapid Diagnostics Adoption to Boost Growth of Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market
Isothermal Nucleic Acid Amplification Technology Market |
Market
Overview:
Isothermal
Nucleic Acid Amplification Technology (INAAT) refers to the method of
amplifying nucleic acid sequences at a constant temperature, eliminating the
need for expensive thermal cycling equipment. INAAT allows for rapid, low-cost
detection of infectious diseases in decentralized healthcare settings. The
major advantage of INAAT over PCR is that it can be performed using portable
battery-operated instruments without the requirement of a stable electricity supply
or specialized laboratory infrastructure. INAAT products are widely used for
point-of-care diagnostics of diseases such as HIV, tuberculosis, influenza, and
more recently COVID-19.
Market Key Trends:
The global INAAT market is driven by the increasing adoption of rapid
diagnostic tests for infectious diseases screening in hospitals, laboratories,
and home care settings. Point-of-care testing using INAAT products allows for
timely diagnosis and treatment, improving health outcomes. Growing awareness about
early disease detection and management is boosting demand for INAAT.
Furthermore, rising R&D investments by leading players for development of
accurate and affordable INAAT tests for new applications are expanding the
market scope over the forecast period.
Porter’s
Analysis
Threat of
new entrants: The threat of new entrants in the Isothermal
Nucleic Acid Amplification Technology (Inaat) Market is moderate.
Existing players have strong distribution networks and brand recognition.
However, low setup costs of INAAT technologies enable new players to enter the
market.
Bargaining power of buyers: The bargaining power of buyers in the INAAT market
is high. Buyers have significant influence due to the presence of alternative
technologies. They can negotiate on price and play suppliers against each
other.
Bargaining power of suppliers: The bargaining power of suppliers is moderate.
Suppliers of critical components and technologies for INAAT have
differentiation in their offerings. However, presence of substitutes limits
their power.
Threat of new substitutes: The threat of new substitutes is high owing to
technological advancements. Newer molecular diagnostic technologies such as
CRISPR provides tough competition to INAAT technologies.
Competitive rivalry: The competitive rivalry in the market is high due to
presence of large number of players offering substitutable products.
Key Takeaways
The global INAAT market is expected to witness high growth, exhibiting CAGR of 8.4% over the forecast period,
due to increasing incidence of infectious diseases. The rise in demand for
easy-to-use, rapid and accurate testing methods for diagnosis of diseases such
as HIV, influenza also supports market growth.
Regionally, North America dominated the global market in 2023 and is expected
to maintain its dominance over the forecast period. This is attributed to
developed healthcare infrastructure, high adoption of advanced diagnostic
technologies, and presence of key market players in the region. Asia Pacific is
expected to exhibit the fastest growth during the analysis period owing to
improving healthcare standards, rising awareness about early diagnosis of
diseases, and increasing healthcare spending in the region.
Key players operating in the INAAT market are Alere Inc., Becton, Dickinson
& Company, BioHelix Corporation, BioMerieux Biotechnology Company, Hologic
Gene-Probe, QIAGEN Company, Thermo Fisher Scientific, Inc., Lucigen
Corporation, Quidel Corporation, and NuGEN. These companies are focused on
expanding their product portfolio and market presence through acquisitions and
collaborations with industries and research institutes.
Read More:
https://www.dailyprbulletin.com/isothermal-nucleic-acid-amplification-technology-inaat-market/
Comments
Post a Comment